Terren S. Peizer - 15 Aug 2022 Form 4 Insider Report for BIOVIE INC. (BIVI)

Role: Director, 10%+ Owner
Signature: /s/ Joanne Wendy Kim, Attorney-in-Fact
Issuer symbol: BIVI
Transactions as of: 15 Aug 2022
Net transactions value: +$6,000,001
Form type: 4
Filing time: 16 Aug 2022, 17:11:21 UTC
Previous filing: 19 May 2022
Next filing: 31 Aug 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BIVI	Common Stock	Award	$6,000,001	+3,636,364	+19%	$1.65	23,166,210	15 Aug 2022	By Acuitas	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BIVI	Warrants (right to buy)	Award		+7,272,728			7,272,728	15 Aug 2022	Common Stock	7,272,728	$1.82	By Acuitas	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On July 15, 2022, BioVie Inc. (the "Issuer") entered into a securities purchase agreement with Acuitas, pursuant to which the Issuer agreed to issue, for an aggregate purchase price of $6,000,000.60, (i) 3,636,364 shares (the "PIPE Shares") of the Issuer's common stock at a price of $1.65 per share, and (ii) a warrant to purchase 7,272,728 shares of the Issuer's common stock at an exercise price of $1.82, with a term of exercise of five years. The Issuer issued the shares and warrants to Acuitas on August 15, 2022.3,636,364 shares (the "PIPE Shares") of the Issuer's common stock at a price of $1.65 per share, and (ii) a warrant to purchase 7,272,728 shares of the Issuer's common stock at an exercise price of $1.82, with a term of exercise of five years. The Issuer issued the shares and warrants to Acuitas on August 15, 2022.
F2	Acuitas Group Holdings, LLC ("Acuitas"), is an entity beneficially owned and controlled by Terren S. Peizer.

Content

On July 15, 2022, BioVie Inc. (the "Issuer") entered into a securities purchase agreement with Acuitas, pursuant to which the Issuer agreed to issue, for an aggregate purchase price of $6,000,000.60, (i) 3,636,364 shares (the "PIPE Shares") of the Issuer's common stock at a price of $1.65 per share, and (ii) a warrant to purchase 7,272,728 shares of the Issuer's common stock at an exercise price of $1.82, with a term of exercise of five years. The Issuer issued the shares and warrants to Acuitas on August 15, 2022.3,636,364 shares (the "PIPE Shares") of the Issuer's common stock at a price of $1.65 per share, and (ii) a warrant to purchase 7,272,728 shares of the Issuer's common stock at an exercise price of $1.82, with a term of exercise of five years. The Issuer issued the shares and warrants to Acuitas on August 15, 2022.

Acuitas Group Holdings, LLC ("Acuitas"), is an entity beneficially owned and controlled by Terren S. Peizer.